However, recommendations regarding genetic testing other than BRCA1 and BRCA2 continue to vary between countries, and the data and testing policy of non-BRCA genes among Thai patients with the hereditary breast-ovarian cancer (HBOC) spectrum remains insufficient. Here, BRCA1 is linked to Hereditary breast and ovarian cancer syndrome.